Consult the medical resource doctors trust

UpToDate is one of the most respected medical information resources in the world, used by over 360,000 doctors and thousands of patients to find answers to medical questions.

  • Content written by a faculty of over 4,000 physicians from leading medical institutions
  • Unbiased: free of advertising or pharmaceutical funding
  • Evidence-based treatment recommendations
  • Continuously updated to incorporate new medical findings

Pharmacologic stress radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease

INTRODUCTION

Stress radionuclide myocardial perfusion imaging (MPI) can, via the presence and extent of perfusion defects, be used to demonstrate the presence of coronary disease and to risk stratify and guide management of patients with known disease. Treadmill or bicycle exercise is the preferred form of stress for patients who can attain an adequate level of exercise (defined as ≥85 of their predicted maximal heart rate) because it provides the most information concerning patient symptoms, cardiovascular function, and the hemodynamic response during usual forms of activity [1-3]. The inability to perform an exercise test is itself a negative prognostic factor in patients with coronary heart disease (CHD). (See "Exercise ECG testing to determine prognosis of coronary heart disease", section on 'Exercise capacity' and "Exercise radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease".)

However, many patients (particularly those who are elderly) are unable to exercise to an adequate level or have contraindications to such testing. Inadequate exercise may lead to an underestimation of the presence and/or severity of CHD. In addition to reducing symptoms and electrocardiographic (ECG) changes, submaximal exercise may reduce the diagnostic accuracy of exercise rMPI [4,5].

The clinical use of pharmacologic stress rMPI for the diagnosis of CHD, for prognosis, and for use in specific settings will be reviewed here. Issues specific to the different pharmacologic agents, such as study protocol, safety, contraindications, and drug interactions, are discussed separately. (See "Pharmacologic stress radionuclide myocardial perfusion imaging: Testing methodologies and safety".)

Pharmacologic stress echocardiography and general discussions on the use of stress testing for the diagnosis and prognosis of known or suspected CHD, including its prognostic role after an acute coronary syndrome or revascularization, and the advantages and limitations of the different stress tests are also discussed elsewhere. (See "Stress echocardiography in the diagnosis and prognosis of coronary heart disease" and "Stress testing for the diagnosis of coronary heart disease" and "Stress testing to determine prognosis and management of patients with known or suspected coronary heart disease" and "Role of stress testing after coronary revascularization" and "Advantages and limitations of different stress testing modalities".)

CHOICE OF TEST MODALITY

The choice among the different types of stress tests is based upon the patient's ability to exercise to a level high enough to produce meaningful results on exercise ECG testing, the possible presence of baseline electrocardiographic abnormalities that could interfere with the interpretation of exercise ECG testing, and whether or not it is important to localize ischemia or assess myocardial viability (algorithm 1 and algorithm 2). As noted above, treadmill or bicycle exercise is the preferred stress in patients who are able to exercise [1-3].

To continue reading this article you need to subscribe.

Read the rest of this article and others like it

The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use (click here) ©2010 UpToDate, Inc.
References Top
  1. Gibbons, RJ, Abrams, J, Chatterjee, K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina. Available at: www.acc.org/qualityandscience/clinical/statements.htm (accessed August 24, 2006).
  2. Gibbons, RJ, Balady, GJ, Bricker, JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002; 106:1883.
  3. Gibbons, RJ, Balady, GJ, Beasley, JW, et al. ACC/AHA guidelines for exercise testing: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997; 30:260.
  4. Iskandrian, AS, Heo, J, Kong, B, Lyons, E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol 1989; 14:1477.
  5. Heller, GV, Ahmed, I, Tilikemeier, PL, et al. Influence of exercise intensity on the presence, distribution, size of thallium-201 defects.
  6. Garber, AM, Solomon, NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med 1999; 130:719.
  7. Marwick, T, D'Hondt, AM, Baudhuin, T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 1993; 22:159.
  8. Forster, T, McNeill, AJ, Salustri, A, et al. Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol 1993; 21:1591.
  9. Mairesse, GH, Marwick, TH, Vanoverschelde, JL, et al. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? Comparison with two-dimensional echocardiography and technetium-99m methoxyl isobutyl isonitrile (mibi) perfusion scintigraphy. J Am Coll Cardiol 1994; 24:920.
  10. Kim, C, Kwok, YS, Heagerty, P, Redberg, R. Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis. Am Heart J 2001; 142:934.
  11. Marwick, T, Willemart, B, D'Hondt, AM, et al. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography. Circulation 1993; 87:345.
  12. Udelson, JE, Heller, GV, Wackers, FJ, et al. Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation 2004; 109:457.
  13. Klocke, FJ, Baird, MG, Lorell, BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003; 42:1318.
  14. Zoghbi, GJ, Htay, T, Aqel, R, et al. Effect of caffeine on ischemia detection by adenosine single-photon emission computed tomography perfusion imaging. J Am Coll Cardiol 2006; 47:2296.
  15. Sharir, T, Rabinowitz, B, Livschitz, S, et al. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol 1998; 31:1540.
  16. Taillefer, R, Ahlberg, AW, Masood, Y, et al. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol 2003; 42:1475.
  17. Bottcher, M, Refsgaard, J, Madsen, MM, et al. Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia. J Nucl Cardiol 2003; 10:345.
  18. Shehata, AR, Gillam, LD, Mascitelli, VA, et al. Impact of acute propranolol administration on dobutamine- induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography. Am J Cardiol 1997; 80:268.
  19. Lee, TH, Boucher, CA. Noninvasive tests in patients with stable coronary artery disease. N Engl J Med 2001; 344:1840.
  20. Fleisher, LA, Beckman, JA, Brown, KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116:e418.
  21. Geleijnse, ML, Elhendy, A, Fioretti, PM, Roelandt, JR. Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol 2000; 36:2017.
  22. Senior, R, Raval, U, Lahiri, A. Prognostic value of stress dobutamine technetium-99m sestamibi single-photon emission computed tomography (SPECT) in patients with suspected coronary artery disease. Am J Cardiol 1996; 78:1092.
  23. Geleijnse, ML, Elhendy, A, van Domburg, RT, et al. Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol 1996; 28:447.
  24. Calnon, DA, McGrath, PD, Doss, AL, et al. Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: Stratification of a high-risk population. J Am Coll Cardiol 2001; 38:1511.
  25. Vaduganathan, P, He, ZX, Raghavan, C, et al. Detection of left anterior descending coronary artery stenosis in patients with left bundle branch block: exercise, adenosine or dobutamine imaging? J Am Coll Cardiol 1996; 28:543.
  26. Casale, PN, Guiney, TE, Strauss, HW, Boucher, CA. Simultaneous low level treadmill exercise and intravenous dipyridamole stress thallium imaging. Am J Cardiol 1988; 62:799.
  27. Pennell, DJ, Mavrogeni, SI, Forbat, SM, et al. Adenosine combined with dynamic exercise for myocardial perfusion imaging. J Am Coll Cardiol 1995; 25:1300.
  28. Thomas, GS, Prill, NV, Majmundar, H, et al. Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality. J Nucl Cardiol 2000; 7:439.
  29. Cramer, MJ, Verzijlbergen, JF, van der Wall, EE, et al. Comparison of adenosine and high-dose dipyridamole both combined with low-level exercise stress for 99Tcm-MIBI SPET myocardial perfusion imaging. Nucl Med Commun 1996; 17:97.
  30. Jamil, G, Ahlberg, AW, Elliott, MD, et al. Impact of limited treadmill exercise on adenosine Tc-99m sestamibi single-photon emission computed tomographic myocardial perfusion imaging in coronary artery disease. Am J Cardiol 1999; 84:400.
  31. Stein, L, Burt, R, Oppenheim, B, et al. Symptom-limited arm exercise increases detection of ischemia during dipyridamole tomographic thallium stress testing in patients with coronary artery disease. Am J Cardiol 1995; 75:568.
  32. Rossen JD, Simonetti I, Marcus ML, Winniford MD. Coronary dilation with standard dose dipyridamole and dipyridamole combined with handgrip. Circulation 1989; 79:566.
  33. Muller, P, Czernin, J, Choi, Y, et al. Effect of exercise supplementation during adenosine infusion on hyperemic blood flow and flow reserve. Am Heart J 1994; 128:52.
  34. Czernin, J, Auerbach, M, Sun, KT, et al. Effects of modified pharmacologic stress approaches on hyperemic myocardial blood flow. J Nucl Med 1995; 36:575.
  35. Navare, SM, Mather, JF, Shaw, LJ, et al. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol 2004; 11:551.
  36. Shaw, LJ, Iskandrian, AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004; 11:171.
  37. Hendel, RC, Layden, JJ, Leppo, JA. Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease. J Am Coll Cardiol 1990; 15:109.
  38. Heller, GV, Herman, SD, Travin, MI, et al. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995; 26:1202.
  39. Stratmann, HG, Tamesis, BR, Younis, LT, et al. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994; 73:647.
  40. Hachamovitch, R, Berman, DS, Kiat, H, et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol 1997; 80:426.
  41. Geleijnse, ML, Elhendy, A, van Domburg, RT, et al. Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in women with chest pain. Am J Cardiol 1996; 77:1057.
  42. Hachamovitch, R, Hayes, SW, Friedman, JD, et al. A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy. J Am Coll Cardiol 2005; 45:722.
  43. Udelson, JE, Selker, HP. Quantitative instruments for predicting risk ... and benefit. J Am Coll Cardiol 2005; 45:730.
  44. Hachamovitch, R, Hayes, SW, Friedman, JD, et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003; 107:2900.
  45. Schinkel, AF, Bax, JJ, Elhendy, A, et al. Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests. Am J Med 2004; 117:1.
  46. Hakeem, A, Bhatti, S, Dillie, KS, et al. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death. Circulation 2008; 118:2540.
white circle LOG IN
white circle DEMO